By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Trevena, Inc. 

Berwyn  Pennsylvania    U.S.A.
Phone: n/a Fax: n/a



Drug Discovery

Company News
Trevena, Inc. (TRVN) CMO To Present At The BioCentury 22nd Annual Future Leaders In The Biotech Industry Conference 3/19/2015 11:28:53 AM
Trevena, Inc. (TRVN) Reports Full Year 2014 Financial Results 3/18/2015 9:57:26 AM
Trevena, Inc. (TRVN) To Host Conference Call On March 18th To Discuss Full Year 2014 Financial Results 3/11/2015 10:26:08 AM
Trevena, Inc. (TRVN) Completes Interim Analysis And Announces Plans For Ongoing Phase 2b BLAST-AHF Trial Of TRV027 In Acute Heart Failure 3/9/2015 11:25:10 AM
Trevena, Inc. (TRVN) CEO To Present At The Barclays Global Healthcare Conference 3/4/2015 11:18:43 AM
Trevena, Inc. (TRVN) CEO To Present At The Cowen and Company 35th Annual Health Care Conference 2/24/2015 10:49:03 AM
Trevena, Inc. (TRVN) Announces Positive Results From Phase 1 Multiple Ascending Dose Study Of TRV734 For Moderate To Severe Acute And Chronic Pain 2/9/2015 9:51:34 AM
Trevena, Inc. (TRVN) CEO To Present At The 17th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference 2/4/2015 9:12:28 AM
Trevena, Inc. (TRVN) Release: TRV027 Phase 2b BLAST-AHF Trial Design Published In Journal Of The American College Of Cardiology: Heart Failure 2/3/2015 11:15:00 AM
Trevena, Inc. (TRVN) Initiates Second Phase 2b Study Of TRV130 For Acute Postoperative Pain 1/7/2015 10:53:05 AM